In a recent study published in Scientific Reports, researchers working at Ohio State University in the United States of America (USA) developed an intranasal subunit vaccine. Study: An intranasal ...
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for approximately 600 million documented cases of coronavirus disease 2019 (COVID-19), with almost 6.5 million deaths.
A nasal therapy, built upon on the application of a new engineered IgM antibody therapy for COVID-19, was more effective than commonly used IgG antibodies at neutralizing the COVID-19 virus in animal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback